# Bankwell Financial Group, Inc.: financial statements, quarterly

BWFG · Nasdaq · CIK 1505732 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bwfg.md) · [Financials](/companies/bwfg/financials.md) · [Filings](/companies/bwfg/filings.md) · [Insiders](/companies/bwfg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bwfg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.3](/filings/0001505732-24-000223.md) | [0.7 d](/filings/0001505732-25-000052.md) | [0.3](/filings/0001505732-25-000089.md) | [0.5](/filings/0001505732-25-000126.md) | [0.6](/filings/0001505732-25-000162.md) | [0.6 d](/filings/0001505732-26-000046.md) | [0.6](/filings/0001505732-26-000074.md) | [0.7](/filings/0001505732-26-000105.md) | [0.8](/filings/0001505732-25-000162.md) | [0.8 d](/filings/0001505732-26-000046.md) | [0.8](/filings/0001505732-26-000074.md) | [0.7](/filings/0001505732-26-000105.md) |
| Interest expense | $m | [25.6](/filings/0001505732-23-000256.md) | [27.1 d](/filings/0001505732-24-000067.md) | [27.1](/filings/0001505732-24-000083.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [3.1](/filings/0001505732-24-000223.md) | [2.9 d](/filings/0001505732-25-000052.md) | [1.3](/filings/0001505732-25-000089.md) | [0.4](/filings/0001505732-25-000126.md) | [0.8](/filings/0001505732-25-000162.md) | [1.1 d](/filings/0001505732-26-000046.md) | [2.1](/filings/0001505732-26-000074.md) | [2.7](/filings/0001505732-26-000105.md) | [3.4](/filings/0001505732-25-000162.md) | [5.1 d](/filings/0001505732-26-000046.md) | [3.1](/filings/0001505732-26-000074.md) | [3.9](/filings/0001505732-26-000105.md) |
| Net income | $m | [9.8](/filings/0001505732-24-000223.md) | [8.5 d](/filings/0001505732-25-000052.md) | [3.8](/filings/0001505732-25-000089.md) | [1.1](/filings/0001505732-25-000126.md) | [1.9](/filings/0001505732-25-000162.md) | [3.0 d](/filings/0001505732-26-000046.md) | [6.9](/filings/0001505732-26-000074.md) | [9.1](/filings/0001505732-26-000105.md) | [10.1](/filings/0001505732-25-000162.md) | [9.1 d](/filings/0001505732-26-000046.md) | [11.3](/filings/0001505732-26-000074.md) | [12.4](/filings/0001505732-26-000105.md) |
| Diluted EPS | $ per share | [1.25](/filings/0001505732-24-000223.md) | not reported | [0.48](/filings/0001505732-25-000089.md) | [0.14](/filings/0001505732-25-000126.md) | [0.24](/filings/0001505732-25-000162.md) | not reported | [0.87](/filings/0001505732-26-000074.md) | [1.14](/filings/0001505732-26-000105.md) | [1.27](/filings/0001505732-25-000162.md) | not reported | [1.41](/filings/0001505732-26-000074.md) | [1.52](/filings/0001505732-26-000105.md) |
| Basic EPS | $ per share | [1.25](/filings/0001505732-24-000223.md) | not reported | [0.48](/filings/0001505732-25-000089.md) | [0.14](/filings/0001505732-25-000126.md) | [0.24](/filings/0001505732-25-000162.md) | not reported | [0.88](/filings/0001505732-26-000074.md) | [1.15](/filings/0001505732-26-000105.md) | [1.28](/filings/0001505732-25-000162.md) | not reported | [1.42](/filings/0001505732-26-000074.md) | [1.55](/filings/0001505732-26-000105.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [3,250](/filings/0001505732-23-000256.md) | [3,215](/filings/0001505732-25-000052.md) | [3,155](/filings/0001505732-24-000083.md) | [3,142](/filings/0001505732-24-000153.md) | [3,161](/filings/0001505732-24-000223.md) | [3,268](/filings/0001505732-26-000046.md) | [3,184](/filings/0001505732-25-000089.md) | [3,237](/filings/0001505732-25-000126.md) | [3,244](/filings/0001505732-25-000162.md) | [3,360](/filings/0001505732-26-000105.md) | [3,374](/filings/0001505732-26-000074.md) | [3,476](/filings/0001505732-26-000105.md) |
| Total liabilities | $m | [2,992](/filings/0001505732-23-000256.md) | [2,950](/filings/0001505732-25-000052.md) | [2,887](/filings/0001505732-24-000083.md) | [2,875](/filings/0001505732-24-000153.md) | [2,893](/filings/0001505732-24-000223.md) | [2,998](/filings/0001505732-26-000046.md) | [2,909](/filings/0001505732-25-000089.md) | [2,953](/filings/0001505732-25-000126.md) | [2,951](/filings/0001505732-25-000162.md) | [3,058](/filings/0001505732-26-000105.md) | [3,062](/filings/0001505732-26-000074.md) | [3,152](/filings/0001505732-26-000105.md) |
| Shareholders' equity | $m | [258](/filings/0001505732-24-000223.md) | [266](/filings/0001505732-26-000046.md) | [268](/filings/0001505732-25-000126.md) | [267](/filings/0001505732-25-000162.md) | [268](/filings/0001505732-25-000162.md) | [271](/filings/0001505732-26-000105.md) | [275](/filings/0001505732-26-000105.md) | [283](/filings/0001505732-26-000105.md) | [293](/filings/0001505732-25-000162.md) | [301](/filings/0001505732-26-000105.md) | [312](/filings/0001505732-26-000105.md) | [324](/filings/0001505732-26-000105.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [12.7 d](/filings/0001505732-24-000223.md) | [(0.5) d](/filings/0001505732-25-000052.md) | [9.0](/filings/0001505732-25-000089.md) | [7.1 d](/filings/0001505732-25-000126.md) | [(0.6) d](/filings/0001505732-25-000162.md) | [14.3 d](/filings/0001505732-26-000046.md) | [3.9](/filings/0001505732-26-000074.md) | [6.5 d](/filings/0001505732-26-000105.md) | [10.3 d](/filings/0001505732-25-000162.md) | [7.5 d](/filings/0001505732-26-000046.md) | [7.7](/filings/0001505732-26-000074.md) | [10.2 d](/filings/0001505732-26-000105.md) |
| Capital expenditure | $m | [0.1 d](/filings/0001505732-24-000223.md) | [0.2 d](/filings/0001505732-25-000052.md) | [0.1](/filings/0001505732-25-000089.md) | [0.4 d](/filings/0001505732-25-000126.md) | [0.1 d](/filings/0001505732-25-000162.md) | [0.0 d](/filings/0001505732-26-000046.md) | [0.1](/filings/0001505732-26-000074.md) | [0.4 d](/filings/0001505732-26-000105.md) | [0.4 d](/filings/0001505732-25-000162.md) | [0.3 d](/filings/0001505732-26-000046.md) | [0.5](/filings/0001505732-26-000074.md) | [0.2 d](/filings/0001505732-26-000105.md) |
| Dividends paid | $m | [1.6 d](/filings/0001505732-24-000223.md) | [1.6 d](/filings/0001505732-25-000052.md) | [1.6](/filings/0001505732-25-000089.md) | [1.6 d](/filings/0001505732-25-000126.md) | [1.6 d](/filings/0001505732-25-000162.md) | [1.6 d](/filings/0001505732-26-000046.md) | [1.6](/filings/0001505732-26-000074.md) | [1.6 d](/filings/0001505732-26-000105.md) | [1.6 d](/filings/0001505732-25-000162.md) | [1.6 d](/filings/0001505732-26-000046.md) | [1.6](/filings/0001505732-26-000074.md) | [1.6 d](/filings/0001505732-26-000105.md) |
| Share repurchases | $m | [0.0 d](/filings/0001505732-24-000223.md) | [0.0 d](/filings/0001505732-25-000052.md) | [0.9](/filings/0001505732-25-000089.md) | [1.0 d](/filings/0001505732-25-000126.md) | [0.2 d](/filings/0001505732-25-000162.md) | [0.0 d](/filings/0001505732-26-000046.md) | [0.9](/filings/0001505732-26-000074.md) | [0.4 d](/filings/0001505732-26-000105.md) | [0.0 d](/filings/0001505732-25-000162.md) | [0.0 d](/filings/0001505732-26-000046.md) | [0.2](/filings/0001505732-26-000074.md) | [0.0 d](/filings/0001505732-26-000105.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [7,612](/filings/0001505732-23-000256.md) | [7,617](/filings/0001505732-24-000083.md) | [7,602](/filings/0001505732-24-000153.md) | [7,634](/filings/0001505732-24-000223.md) | [7,688](/filings/0001505732-25-000089.md) | [7,724](/filings/0001505732-25-000126.md) | [7,721](/filings/0001505732-25-000162.md) | [7,741](/filings/0001505732-26-000074.md) | [7,820](/filings/0001505732-26-000105.md) | [7,845](/filings/0001505732-25-000162.md) | [7,801](/filings/0001505732-26-000074.md) | [7,981](/filings/0001505732-26-000105.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 7,971,972 at 2026-07-30, from the cover of the [10-Q filed 2026-08-05](/filings/0001505732-26-000105.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.